Equity
€71,644 ▲ 300%
Equity rose in 2025 from €17,932 to €71,644.
Apotheek Van den Bergh
Lifetime
2 annual accounts with figures on one time axispeak €184,631 (2025)
€184,631▲ 113%
peak €53,712 (2025)
€53,712▲ 350%
peak €71,644 (2025)
€71,644▲ 300%
€445,308▼ 9.5%
Board1 name since 2024
1 directorVAN DEN BERGH Isabelle François Diane
Documentsfilings and deeds
04-08-20264 days late
2025micro format
Gross margin from €86,703 to €184,631Result from €11,932 to €53,712Equity from €17,932 to €71,644Cash from €41,363 to €72,118
Key points
from the 2025 annual accountsDebts
€445,308 86% of the balance sheet
Financial debts 19%Suppliers 6%Taxes and wages 4%Other 71%
Of this, €359,842 falls due within a year.
Position in the sector
€53,712
Higher net result than 89% of companies in retail trade. Sector median €5,059 · 22,852 companies.
2025 accounts filed 4 days after the deadline
Checked score
69
Healthy
Financially stronger than 57% of micro companies in retail trade (NACE 47)
Probability in this band: 0.55% to 1.5%
Bankruptcy probability within 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.6% across 40,280 companies (NACE 47, micro).
About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
06-2025: 1.8%
07-2025: 1.9%▲ +0.1 percentage points vs 06-2025
08-2025: 1.9%● unchanged vs 07-2025highest value
09-2025: 1.1%▼ -0.8 percentage points vs 08-2025
10-2025: 1.1%● unchanged vs 09-2025
11-2025: 1.1%● unchanged vs 10-2025
12-2025: 1.1%● unchanged vs 11-2025
01-2026: 1.2%▲ +0.1 percentage points vs 12-2025
02-2026: 1.2%● unchanged vs 01-2026
03-2026: 1.2%● unchanged vs 02-2026
04-2026: 1.2%● unchanged vs 03-2026
05-2026: 1.4%▲ +0.2 percentage points vs 04-2026
06-2026: 1.3%▼ -0.1 percentage points vs 05-2026
07-2026: 1.4%▲ +0.1 percentage points vs 06-2026
08-2026: 1.8%▲ +0.4 percentage points vs 07-2026
09-2026: 0.8%▼ -1.0 percentage point vs 08-2026
10-2026: 0.8%● unchanged vs 09-2026lowest value
11-2026: 0.8%● unchanged vs 10-2026lowest value
Financial strengthAverage
Score breakdown
raises risk
Founded in 2024
Equity €71,644 (13.9% of total assets)
Sector: Retail trade (NACE 47)
lowers risk
Size: total assets €516,952
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 30% of them on solvency, 27% on liquidity, 74% on profitability and 97% on growth.
The bankruptcy probability was computed on 06-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 7,976 companies had the same profile as Apotheek Van den Bergh has now. Each dot stands for 20 companies, two years later.
94.4%
were still trading
1.8%
stopped another way
3.6%
went bankrupt
Another 0.3% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of Apotheek Van den Bergh itself: 0.8% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 7,976 companies, not a prediction for Apotheek Van den Bergh. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €4,500 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.68 (0.53 in 2024), below 1. Short-term debt is 69.6% and cash 14% of total assets. 86.1% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 4 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-08-2026, 4 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 2 filingsDeviation from the deadline
2025
4 days late
2024
20 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 2 accounts on average 12 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsWhere today falls in the filing period
07-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- VAN DEN BERGH Isabelle François Diane 1,000 sharesdeed of 10-05-2024
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1009186713
Incorporation
Founding capital of €6,000, 1,000 shares · Founder: VAN DEN BERGH Isabelle François Diane · Appointment: VAN DEN BERGH Isabelle François Diane (director) · published on 10-05-2024 · Gazette deed
First establishment
Molenstraat 9, Kontich
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Apotheek Van den Bergh Kontich | €516,952 | €184,631 | 13.9% | - |
| APOTHEEK DEMOL TERHAGEN Willebroek | €570,244 | €214,628 | 33.7% | - |
| Apotheek Sint-Dimpna Geel | €539,460 | €245,855 | 20.5% | 1 |
| ESPERANTO Ledegem | €573,018 | €191,859 | 10.2% | - |
| PHARMACIE JANSSEN Oupeye | €518,745 | €156,285 | 4.6% | - |
| CURAVALEAS Antwerp | €650,626 | €216,787 | 4.2% | - |
| Apotheek Ten Aard Geel | €389,598 | €217,058 | 4.3% | - |
These companies have the same main activity as Apotheek Van den Bergh: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €390,000 and €651,000, founded in 2024.
Official details
Source: KBO- Status
- Active since 07-05-2024Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.359.417.1122550 Kontich, since 07-05-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 04-12-2025
Annual accounts 2025
- ≈ €560,000estimated
- €516,952▲ 1.4%
- Employeeson 31-12-2025
- 1=
- Filing
- Filed on 04-08-2026
Insights on Apotheek Van den Bergh
Apotheek Van den Bergh has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €71,644 and a net result of €53,712.
Its solvency ranks better than 33% of 22,869 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Apotheek Van den Bergh
- What is the company number of Apotheek Van den Bergh?
- The company number of Apotheek Van den Bergh is 1009.186.713. The VAT number is the same number with BE in front: BE 1009.186.713.
- Where is Apotheek Van den Bergh based?
- The registered office is at Molenstraat 9, 2550 Kontich.Company details
- What does Apotheek Van den Bergh do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Apotheek Van den Bergh?
- Apotheek Van den Bergh is a private limited company (BV).
- When was Apotheek Van den Bergh founded?
- Apotheek Van den Bergh was founded on 07-05-2024.
- Is Apotheek Van den Bergh still active?
- Yes, Apotheek Van den Bergh is an active enterprise in the KBO register.
- How many employees does Apotheek Van den Bergh have?
- Apotheek Van den Bergh had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does Apotheek Van den Bergh fall under?
- In its 2025 annual accounts, Apotheek Van den Bergh states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of Apotheek Van den Bergh?
- The turnover in financial year 2025 is ≈ €560,000. This figure is estimated from the gross margin of €184,631 and 31 comparable companies (NACE 477). It probably lies between €390,000 and €1.1m.
- Is Apotheek Van den Bergh profitable?
- In financial year 2025, Apotheek Van den Bergh made a profit of €53,712.
- Where can I find the annual accounts of Apotheek Van den Bergh?
- Apotheek Van den Bergh filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Apotheek Van den Bergh due?
- Apotheek Van den Bergh must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.